Results 281 to 290 of about 213,484 (340)

ERH regulates type II interferon immune signaling through post-transcriptional regulation of JAK2 mRNA. [PDF]

Nucleic Acids Res
Soderholm A, Vunjak M, de Almeida M, Popitsch N, Podvalnaya N, Araguas-Rodriguez P, Scinicariello S, Nischwitz E, Butter F, Ketting RF, Ameres SL, Müller-McNicoll M, Zuber J, Versteeg GA.   +13 more
europepmc   +1 more source

Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria.

, 1993
S L Liu, Andrew Hessel, K E Sanderson
openalex   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Characteristics and Expression Profiles of Identified <i>WRKY</i> Genes in Barley Landraces Under Cold Stress. [PDF]

Int J Mol Sci
Zhou Y, Wang Y, Gao T, Cao Y, Yao Y, Zhao Y, Wang Z.   +6 more
europepmc   +1 more source

Epigenotoxicity: Decoding the epigenetic imprints of genotoxic agents and their implications for regulatory genetic toxicology

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Regulatory genetic toxicology focuses on DNA damage and subsequent gene mutations. However, genotoxic agents can also affect epigenetic marks, and incorporation of epigenetic data into the regulatory framework may thus enhance the accuracy of risk assessment.
Roger Godschalk, Christopher Faulk, Jessica LaRocca, Jan van Benthem, Francesco Marchetti   +4 more
wiley   +1 more source

Classification and Quantification of Unproductive Splicing Events. [PDF]

Acta Naturae
Zavileyskiy LG, Chernyavskaya EA, Vlasenok MA, Pervouchine DD.   +3 more
europepmc   +1 more source

Site-specific recombination determined by I-SceI, a mitochondrial group I intron-encoded endonuclease expressed in the yeast nucleus.

, 1992
Anne Plessis, Arnaud Perrin, James E. Haber, Bernard Dujon   +3 more
openalex   +2 more sources

Evolutionary dynamics of the calcium/cation antiporter superfamily in Brassicaceae: codon usage, selection pressure, and <i>BnCaCAs</i> role in abiotic stress response. [PDF]

Front Plant Sci
Abedi A, Pourkarimi Daryakenari M, Zare F, Allahi S, Hajiahmadi Z.   +4 more
europepmc   +1 more source

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

Epilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola, Marica Rubino, Antonella Riva, Pasquale Striano   +3 more
wiley   +1 more source

Exploring the Potential and Advancements of Circular RNA Therapeutics

Exploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu   +6 more
wiley   +1 more source